Abstract

Sally Kornbluth Photo courtesy of Duke University
Sally Kornbluth, PhD, James B. Duke Professor in the department of pharmacology and cancer biology at Duke University and the vice dean for basic science in Duke's School of Medicine, has been named provost at Duke University. She succeeds Peter Lange, PhD, who steps down on June 30 after serving in the post for 15 years.
Dr. Kornbluth has served on the faculty at Duke since 1994 and has held a number of leadership roles. She was appointed vice dean for basic sciences at the medical school in 2006 and is recognized for her role in directing the School of Medicine's clinical research enterprise from 2009–2011. She has been recognized as an outstanding educator with the School of Medicine's Basic Science Research Mentoring Award in 2012 and the Distinguished Faculty Award from the Duke Medical Alumni Association in 2013.
Dr. Kornbluth earned a bachelor of science in genetics in 1984 from Cambridge University, where she was a Herchel Smith Scholar at Emmanuel College. She earned her PhD in molecular oncology from the Rockefeller University in 1989 and completed postdoctoral training at the University of California, San Diego. Her research has focused on cell proliferation and programmed cell death. She is a member of the Institute of Medicine and a fellow of the American Association for the Advancement of Science.
Dean of LSU Health Shreveport School of Medicine Retires
Andrew L. Chesson, Jr. MD, Dean of the School of Medicine at Louisiana State University (LSU) Health Sciences Center Shreveport (LSUHSC-S), retired in March 2014. He spent his entire career of more than 35 years at LSU Health Shreveport. He was a Professor of Neurology, also serving as Associate Dean for Academic Affairs for 15 years and Acting Chancellor and Dean for one year, and was the inaugural holder of the separate title of Dean of the School of Medicine under the Chancellor/Dean organizational structure.
Dr. Chesson is recognized for his expertise in sleep medicine. He developed and served as Director of the LSUHSC-S Sleep Disorder Center and was Director of the Sleep Medicine Fellowship Program. He is a founding member of the Louisiana Sleep Society and a past-president of the American Academy of Sleep Medicine (AASM). He has received numerous honors for his work, including the Humanism in Medicine Award given by the Association of Academic Medical Centers and Pfizer and the AASM's Distinguished Service Award. Dr. Chesson earned his MD from the University of Texas Medical Branch, where he also completed his internship and residency in neurology.
John Marymont, MD MBA, Chief of Orthopedic Surgery at LSUHSC-S, is serving as Interim Dean. Dr. Marymont earned his MD from Vanderbilt Medical School and completed orthopedic residency at the University of Texas Health Science Center at Houston. He completed a fellowship in Sports Medicine at the Cleveland Clinic Foundation as well as a fellowship in Foot and Ankle Surgery at the New England Baptist Hospital, an affiliate of Tufts University. He holds an MBA degree from the Jesse H. Jones School of Business at Rice University, where he also earned a Certificate in Healthcare and Medical Management. He served on the faculty at Baylor College of Medicine (BCM) in Houston prior to joining LSU. At BCM, he held a number of leadership responsibilities. He was Chief of the Foot and Ankle Service, Residency Program Director and tenured Professor.
Cwru Names Vice Dean for Medical Education
Patricia Thomas, MD, FACP, assumed the post of Vice Dean for Medical Education at Case Western Reserve University (CWRU) School of Medicine in February this year. She previously served at Johns Hopkins University School of Medicine for 25 years, where she was associate dean for curriculum. While at Johns Hopkins, Dr. Thomas led development of the school's innovative Genes to Society curriculum and provided key leadership in the development of Hopkins’ Anne and Mike Armstrong Medical Education Building. In her post at CWRU, she oversees all medical education and teaching programs of the School of Medicine.
Dr. Thomas earned her MD from Rutgers Medical School in 1976 and completed postdoctoral training at Rutgers and George Washington University Medical Center in Washington DC. She is board certified in Internal Medicine, Rheumatology and Geriatrics. She is a co-author of the educational guide, Curriculum Development for Medical Education – A Six Step Approach.
Ucsf Helen Diller Cancer Center Names Director
Alan Ashworth Photo courtesy of The Institute of Cancer Research
Alan Ashworth, PhD, FRS, has been named as the new director of the UCSF Helen Diller Family Comprehensive Cancer Center at the University of California San Francisco (UCSF). The Center is a National Institutes of Health's (NIH's) National Cancer Institute (NCI)-designated comprehensive cancer center. Dr. Ashworth will formally begin his new post at UCSF in January 2015.
Dr. Ashworth succeeds the Center's founding director, Frank McCormick, PhD, FRS. Dr. McCormick will remain on the faculty at UCSF cancer center as he assumes a national leadership role as director of the NIH's RAS Project, a project of the NCI. Peter R. Carroll, MD, MPH, began serving as interim director on April 1. Dr. Carroll is associate dean of the UCSF School of Medicine and chair of the UCSF Department of Urology, and he leads the prostate cancer program at the UCSF cancer center.
Dr. Ashworth joins UCSF from The Institute of Cancer Research (ICR) in London, England, where he has served for 28 years. He is chief executive of the ICR and also serves as professor of molecular biology and leader of the gene function team in The Breakthrough Breast Cancer Research Centre at the ICR. His research has focused on genes involved in cancer risk. He was part of the team that discovered the gene BRCA2, and his continued work has been pivotal in developing approaches to cancer therapy. He has earned numerous honors for his work, including the European Society of Medical Oncology Lifetime Achievement Award. He is an elected member of the Academy of Medical Sciences as well as an elected Fellow of the Royal Society (FRS).
Umd Names Head of Division of Cardiovascular Medicine
Sanjay Rajagopalan Photo credit: Thomas Jemski Courtesy of University of Maryland School of Medicine
Sanjay Rajagopalan, MD, FACC, FAHA, has been named as head of the Division of Cardiovascular Medicine at the University of Maryland (UMD). He will also hold the Melvin Sharoky Endowed Professorship in Cardiovascular Medicine at the School of Medicine and will serve on the leadership team of the Division of Cardiac Surgery to support the UM Comprehensive Heart Center. He previously served as the John W. Wolfe Professor of Cardiovascular Medicine at the Wexner Medical Center at the Ohio State University College of Medicine in Columbus, Ohio, where he was also the Associate Director of the Davis Heart and Lung Institute.
Dr. Rajagopalan is recognized for his expertise on the topic of environmentally induced heart disease. He completed clinical and research fellowships in cardiovascular medicine and vascular biology at the Emory University School of Medicine in Atlanta, Georgia, and advanced cardiovascular imaging training at Duke University in North Carolina. He has previously served in faculty positions at the University of Michigan, Ann Arbor, and at the Mount Sinai School of Medicine in New York. His research has focused on the role of inflammation in cardiometabolic disease and molecular imaging of atherosclerosis, and his work is supported with funding from the National Institutes of Health. He has received numerous awards and honors, including the William Keating Award from the American College of Cardiology and the Charles A. Dana Award, given by the Dana Foundation.
Yerkes National Primate Research Center Appoints New Director
R. Paul Johnson Photo courtesy of the New England Primate Research Center
R. Paul Johnson, MD, has been appointed as director of Emory University's Yerkes National Primate Research Center. His assumes the post on August 1, 2014 and will succeed Stuart Zola, PhD, who directed the Center since 2001. Dr. Zola is stepping down from the directorship of Yerkes to continue his research on memory in Emory's Department of Psychiatry and Behavioral Sciences and at the Atlanta Veterans Affairs Medical Center. Dr. Johnson is director of the New England Primate Research Center (NEPRC), chairman of the NEPRC Division of Immunology and professor of medicine at Harvard Medical School (HMS) and Massachusetts General Hospital.
Among other leadership roles held during his tenure at HMS, Dr. Johnson was director of the Developmental Research Core for the Harvard Center for AIDS Research and associate director of the Harvard Committee on Microbiologic Safety. His research interests include identification of immune responses that can protect against HIV infection, and he is a member of the American Society for Clinical Investigation and a Fellow of the Infectious Disease Society of America. He is Board Certified in Internal Medicine with a Certification in Infectious Diseases. He has received numerous honors for his work, including the Elizabeth Glaser Pediatric AIDS Foundation's Elizabeth Glaser Scientist Award.
Dr. Johnson earned his MD at HMS. He served as chief resident at Yale-New Haven Hospital and as a clinical and research fellow in infectious disease at Massachusetts General Hospital in Boston.
Chairman of Department of Family and Community Health Named at Marshall SOM
Stephen M. Petrany Photo courtesy of Joan C. Edwards School of Medicine -Marshall University
Stephen M. Petrany, MD, has been named chairman of the department of family and community health at Marshall University's Joan C. Edwards School of Medicine. He succeeds John Walden, MD, who is transitioning into a new role within the school. Dr. Walden served in the post for five years. Dr. Petrany is a professor in the department and has been a full-time faculty member since 1989. Prior to his selection as chair, he had served as interim chair for several months.
Dr. Petrany earned his MD from Georgetown University School of Medicine and completed residency in family medicine at the Medical College of Virginia. He is on the board of directors and serves as medical director for Ebenezer Medical Outreach, Inc. He is recognized as a leading educator and is co-director and co-developer of the Paul Wesley Ambrose Health Policy Residency Track, the first of its kind in the nation. In 2013, he was awarded the Dean's Award for Excellence in Medical Education.
Vice Dean for Education Named at Feinberg
Diane B. Wayne Photo courtesy of Northwestern University Feinberg School of Medicine
Diane B. Wayne, MD, has been named Vice Dean for Education at Northwestern University Feinberg School of Medicine.
Dr. Wayne is the Dr. John Sherman Appleman Professor of Medical Education, Vice-Chair of the Department of Medicine and Associate Chief Medical Officer for Medicine, Women's Health and Psychiatry at Northwestern Memorial Hospital. She earned her undergraduate and medical degrees at Northwestern and completed residency in internal medicine at the University of Chicago hospitals. She joined the faculty at Northwestern medical school in 1994. From 2001 to 2012, Dr. Wayne served as the program director of the Internal Medicine residency at McGaw Medical Center of Northwestern University.
Dr. Wayne's research has focused on studying the effect of medical education on the quality of patient care. She has been honored with numerous awards for her work, including the 2007 National Award for Medical Education Scholarship from the Society of General Internal Medicine and the Thomas Hale Ham Award for New Investigators from the Association of American Medical Colleges. She was awarded the Parker Palmer Courage to Teach National Program Director Award from the Accreditation Council of Graduate Medical Education in 2010 and, in 2013, she was awarded the Leader in General Internal Medicine Award from the Midwest Society of General Internal Medicine.
Associate Dean for Graduate Medical Education Appointed at UVM
Mark A. Levine Photo courtesy of University of Vermont College of Medicine
Mark A. Levine, MD, FACP, has been appointed associate dean for graduate medical education at the University of Vermont (UVM) College of Medicine. He succeeds David Adams, MD, professor and interim chair of anesthesiology. Dr. Levine has served as director of the Internal Medicine Residency Program since 1992 and is also associate chair for education in the Department of Medicine. In his new role, he will also be designated institutional official at Fletcher Allen Health Care.
Dr. Levine earned his MD at the University of Rochester School of Medicine in New York. He completed residency in internal medicine at UVM/Medical Center Hospital of Vermont, serving as chief resident from 1982 to 1983, and fellowship in general internal medicine at the University of North Carolina. Prior to joining the UVM/Fletcher Allen faculty, Dr. Levine was program director of the internal medicine residency program at Geisinger Medical Center in Danville, PA. He also previously served at the Thomas Jefferson Medical College as associate professor of medicine.
Dr. Levine is a Fellow of the American College of Physicians, for which he served as Governor of the Vermont Chapter from 2007 to 2011. He was appointed Councilor of the Association of Program Directors of Internal Medicine and is active in the Alliance for Academic Internal Medicine and the Clerkship Directors of Internal Medicine. He is a two-time recipient of the E.L. Amidon Award for Teaching Excellence in the Department of Medicine and, in 2003, was named Clinical Teacher of the Year.
Professor and University Chair of Urology Named at Montefiore and Einstein
Mark Schoenberg, MD, has been named professor and university chair of The Department of Urology at Montefiore Medical Center and Albert Einstein College of Medicine of Yeshiva University. Dr. Schoenberg joined Einstein in April, prior to which he served as The Bernard L. Schwartz Distinguished Professor of Urology and Director of Urologic Oncology at Johns Hopkins Medicine.
Dr. Schoenberg earned his MD from the University of Texas Health Sciences Center in 1986. He completed residency in General Surgery and Urology at the Hospital of The University of Pennsylvania, where he served as chief resident and urology instructor. He completed basic research and clinical urologic oncology fellowships at Johns Hopkins. His primary academic focus and area of clinical expertise is the treatment of patients with bladder cancer. His research has focused on early detection methods for cancer and novel therapies to treat urologic malignancies. He is former chair of the Medical Advisory Board of the Bladder Cancer Advocacy Network and is the author of The Guide to Living with Bladder Cancer. He also co-edited The Textbook of Bladder Cancer.
Director of New Institute for Critical Care Medicine at Ichan Appointed
Stephan A. Mayer Photo courtesy of Mount Sinai Health System
Stephan A. Mayer, MD, has been appointed Director of the new Institute for Critical Care Medicine at Icahn School of Medicine at Mount Sinai. He joins Mount Sinai from New York-Presbyterian Hospital/Columbia University Medical Center where he was Director of the Neurological Intensive Care Unit for 20 years.
Dr. Mayer is an internationally recognized neurointensivist and has served as principal investigator of the National Institutes of Health-funded Neurological Emergencies Treatment Trials (NETT) hub at New York-Presbyterian Hospital, and of Columbia University's Subarachnoid Hemorrhage Outcomes Project. His work has been supported with funding from the Charles A. Dana Foundation, General Electric, IBM, Draper Laboratories, and the Department of Defense.
Dr. Mayer earned his medical degree from Weill Cornell Medical College and completed medical internship, neurology residency, and neurocritical care fellowship training at Columbia University Medical Center. He is a founding member and former president of the Neurocritical Care Society. Among his many other publications, Dr. Mayer is a co-author of the textbooks, Therapeutic Hypothermia and Neurological and Neurosurgical Intensive Care.
Uams Names Director of Psychiatric Research Institute
Pedro L. Delgado Photo courtesy of UAMS
Pedro L. Delgado, MD, has been named director of the University of Arkansas for Medical Sciences (UAMS) Psychiatric Research Institute and the Marie Wilson Howells Professor and chair of the Department of Psychiatry in the College of Medicine. He joined UAMS on April 1, prior to which he served as professor and chairman of the University of Texas Health Science Center (UTHSC) in San Antonio's Department of Psychiatry. He also served as associate dean for faculty development and professionalism and held the Dielmann Distinguished Chair in Psychiatry at UTHSC since 2005.
Dr. Delgado earned both his MD and MA in pharmacology from the University of Texas Medical Branch in Galveston. He completed internship and residency in psychiatry at Yale University, where he subsequently served on the faculty before moving to the University of Arizona College of Medicine in 1992. While at the University of Arizona, he held a number of leadership roles, including associate chairman for research in the Department of Psychiatry and assistant chief of psychiatry at the Tucson Veterans Affairs Medical Center. He also previously served as chairman of the Department of Psychiatry and the Douglas Danford Bond Professor of Psychiatry at Case Western Reserve University and University Hospitals of Cleveland.
Dr. Delgado's research has focused on the molecular genetics of mood and anxiety disorders, and the neurobiological mechanisms of antidepressants. His work has been funded by the National Institutes of Health (NIH) and he has served on a number of review panels for the NIH's National Institute of Mental Health and other NIH institutes. He is board certified in psychiatry.
Uams Translational Research Institute Names Director, Associate Director
Laura James Photo courtesy of UAMS
Cornelia Beck Photo courtesy of UAMS
Laura James, MD, has been named as director of the University of Arkansas for Medical Sciences (UAMS) Translational Research Institute (TRI), and Cornelia Beck PhD, RN, will serve as the Institute's associate director. The TRI is designated by the National Institutes of Health as a part of the Clinical and Translational Science Award (CTSA) program.
Dr. James succeeds Curtis Lowery, MD, as director. Dr. Lowery is stepping down as director and principal investigator to focus on his responsibilities as chair of the UAMS College of Medicine Department of Obstetrics and Gynecology and director of the UAMS Center for Distance Health. As such, Drs. James and Beck were also named co-principal investigators of UAMS’ CTSA.
Dr. James is a professor in the College of Medicine Department of Pediatrics. Her research has focused on acetaminophen toxicity, and she oversees clinical trials addressing the appropriate and safe use of a variety of medications in children. She previously served as the director of the Pediatric Pharmacology Research Unit at Arkansas Children's Hospital (ACH) and is section chief of Clinical Pharmacology and Toxicology at ACH.
Dr. Beck is a professor in the College of Medicine Department of Geriatrics and the Louise Hearne Endowed Chair in Dementia and Long-term Care. She has served as a co-director for the TRI for the past five years. Her research has centered on improving the care of individuals diagnosed with Alzheimer's disease, and she has conducted clinical trials of non-pharmacologic therapies to treat Alzheimer's patients. She is co-director of the UAMS John A. Hartford Center for Geriatric Nursing Excellence and has led the research enterprise of that center for the past 12 years.
New Associate Director for Basic Science Named at UMD Greenebaum Cancer Center
Richard L. Eckert, Ph.D. Photo credit: Thomas Jemski Courtesy of University of Maryland School of Medicine
Richard L. Eckert, PhD, John F.B. Weaver Professor and Chair of the Department of Biochemistry & Molecular Biology at the University of Maryland (UMD) School of Medicine, has been named Associate Director for Basic Science at the UMD Marlene and Stewart Greenebaum Cancer Center (GCC). He succeeds interim Associate Director of Basic Sciences, Amy Fulton, PhD, who served in the post following the departure of Alan Tomkinson, PhD in 2011. Dr. Eckert will continue his departmental leadership role in his new post.
Dr. Eckert earned his PhD from the University of Illinois-Urbana. He completed post-doctoral work at the Massachusetts Institute of Technology in the Department of Cell Biology and at Harvard Medical School in the Department of Physiology and Biophysics. He joined the faculty of the Case Western Reserve University (CWRU) School of Medicine as an assistant professor of Physiology and Biophysics, Dermatology, Reproductive Biology, Oncology, and Biochemistry in 1986. He was a tenured professor at CWRU prior to joining the UMD School of Medicine as Professor and Chair of the Department of Biochemistry & Molecular Biology in January 2007.
Dr. Eckert's research has centered on understanding how normal surface epithelial cells function to protect people from illnesses and how those cells are altered during disease states, including skin cancer. He serves as principal investigator on numerous grants from the National Institutes of Health. His work is also supported with funding from the Department of the Navy, the American Cancer Society, the Dermatology Foundation, the American Institute for Cancer Research and the Congressionally Directed Medical Research Program Breast Cancer Research Program.
